Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088101

« Back to Dashboard

NDA 088101 describes NAFAZAIR, which is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs. Additional details are available on the NAFAZAIR profile page.

The generic ingredient in NAFAZAIR is naphazoline hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride profile page.

Summary for 088101

Tradename:	NAFAZAIR
Applicant:	Pharmafair
Ingredient:	naphazoline hydrochloride
Patents:	0
Therapeutic Class:	Ophthalmic Agents
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 088101

Adrenergic alpha-Agonists
Nasal Decongestants

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.1%
Approval Date:	Apr 15, 1983	TE:		RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School

US Army

McKinsey

Deloitte

Federal Trade Commission

Moodys

Dow

Baxter

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.